Standard 6
People with diabetes should be offered blood pressure, blood lipid and anti-platelet therapy to lower cardiovascular risk when required in accordance with current recommendations.
Key practice points
In addition to glycaemic control, people with diabetes should be offered medication to address their other cardiovascular risk factors.
Cardiovascular risk assessment should be calculated annually from time of diagnosis for adults with type 1 or type 2 diabetes.
People with diabetes with a cardiovascular risk >20% should be on a statin.
Read this standard in conjunction with the equality and diversity section in the Introduction to the Toolkit.
Dostları ilə paylaş: | 
